Work

SUR2A: An Overlooked Adaptive Effector of Cardioprotection

Year: 2026
Type: article
Abstract: Despite decades of intensive investigation, translation of experimental cardioprotection into effective clinical therapies remains limited. Research has largely focused on upstream signaling networks, including RISK, SAFE, NO/cGMP/PKG and AMPK, whereas the downstream effectors that determine myocardial stress resistance have received comparatively less attention. This review examines sulfonylurea receptor 2A (SUR2A), the regulatory subunit of the cardiac sarcolemmal ATP-sensitive potassium (KATP) channel, as a potential adaptive effector of cardioprotection. Experimental evidence indicates that SUR2A abundance can limit functional KATP-channel assembly and that moderate increases in SUR2A enhance resistance to metabolic stress and ischemia–reperfusion injury. SUR2A expression is dynamically regulated by hypoxia, AMPK, ERK1/2, PI3K/Akt, estrogen and nicotinamide, providing potential links between established cardioprotective signaling and sustained channel remodeling. However, paradoxical protection after SUR2 deletion, limited isoform-specific loss-of-function studies and sparse human validation indicate that SUR2A cannot yet be regarded as an established common effector. We propose an effector-centric framework in which SUR2A represents a plausible, but incompletely validated, convergence point linking metabolic signaling to electrical and energetic adaptation, and identify the experiments required to test its translational relevance.
Source: Biomedicines
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,137
OpenAlex ID: W7234815195
FWCI:
Cites: 61
Cited by:
Related to: 10